BDBM247966 US9434724, 44

SMILES Cc1cc(F)cc2[nH]cc(C(=O)OCC34CCN(CC3)CC4)c12

InChI Key InChIKey=HEMPDMBOSVBORY-UHFFFAOYSA-N

Data  1 KI  7 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 247966   

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247966(US9434724, 44)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 3A4(Human)
Alpharmagen

US Patent
LigandPNGBDBM247966(US9434724, 44)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 2D6(Human)
Alpharmagen

US Patent
LigandPNGBDBM247966(US9434724, 44)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 1A2(Human)
Alpharmagen

US Patent
LigandPNGBDBM247966(US9434724, 44)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 2C9(Human)
Alpharmagen

US Patent
LigandPNGBDBM247966(US9434724, 44)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetCytochrome P450 2C19(Human)
Alpharmagen

US Patent
LigandPNGBDBM247966(US9434724, 44)
Affinity DataIC50: 1.00E+4nMT: 2°CAssay Description:Protocol 1: Studies were carried out in human liver microsomes. Human liver microsomes were purchased from BD Gentest. DMSO stocks were prepared for ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent

TargetNeuronal acetylcholine receptor subunit alpha-7(Rat)
Alpharmagen

US Patent
LigandPNGBDBM247966(US9434724, 44)
Affinity DataKi:  412nM ΔG°:  -9.05kcal/mole IC50: 480nMpH: 7.4 T: 2°CAssay Description:Protocol 1: The assay was conducted following the literature reference Meyer E. M., et al., Analysis of 3-(4-Hydroxy, 2-Methoxybenzylidene) Anabasein...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2017
Entry Details
Go to US Patent